TrialPsychiatry and clinical neurosciences2025

Efficacy and safety of SDT-001, a dual-task digital device, in managing attention-deficit/hyperactivity disorder symptoms in children and adolescents: a phase 3, randomized, standard treatment-controlled study.

Katsunaka Mikami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.